Last month we attended ACC.15, the American College of Cardiology 64th Annual Scientific Session and Expo in San Diego, CA. It was a great venue to interact with the physician community and to hold our first ever CorPath Physicians Users Group meeting. This peer-to-peer meeting enabled physicians from across academic and community hospitals to meet to discuss their experiences with CorPath System and how robotics is integrated into their practice. This is what we heard:
- Occupational hazards in the cath lab are real, and the use of the CorPath Vascular Robotic System is significantly reducing these hazards
The participants had a meaningful discussion about the occupational hazards of Interventional Cardiology, and the obligation to lead future generations in performing PCI in a way that’s safe for patients and clinicians. Users recognize that the CorPath system is reducing their radiation exposure and risk of orthopedic injury and disability, and discussed best practices in when and how to help fellows learn this new technology.
Users shared that the use of the system was nurturing a culture of radiation safety in the lab. Not only are they benefiting from the significant reduction in the occupational hazards associated with coronary interventions, but also the staff is becoming more cognizant of the steps they can take to reduce radiation exposure during a procedure, creating a safer environment for all.
- CorPath Vascular Robotics System is being used in complex PCIs
Participating physicians discussed a broad range of complex and high-risk CorPath cases. The CorPath System is being used across a range of cases, and the group reviewed example cases including robotic-assisted STEMIs, complex lesions, and CorPath cases using adjunct technologies.
Experienced users presented case specifics and shared tips that they employ during complex CorPath cases, including guide catheter and guidewire selection and best practices for manipulating the joysticks and robotically navigating tortuous anatomy, or a calcified or previously stented vessel.
In addition to developing best practices for optimal usage of the system, all users highlighted the importance of preparing their teams ahead of time to optimize workflow. This is particularly crucial in STEMI cases where time is of the essence.
The peer-to-peer discussion highlighted the value of continued learning in developing robotic expertise for more complex cases, and emphasized what we already know – that the physician community is an active and valuable partner with Corindus in providing feedback and best practices in the use of our robotics platform.
- Developing a ’robotics first’ mindset is crucial for success
Our users are excited to adopt cutting edge technology and innovation in medicine that will help their patients and themselves. In order to fully integrate CorPath into their practice and to get most out of the system, advanced users of CorPath recommend embracing the change to robotic PCI and developing a ‘robotics first’ mindset. Advanced users highlighted this change to ‘robotics-first’ mindset to be the cornerstone of their robotics program. They said it has enabled them to optimize workflow to improve efficiency, reduce radiation exposure risk and develop proficiency in performing robotic PCIs. The most successful physician users have adopted this ‘robotics first’ mindset, and are performing all interventions robotically unless mitigating factors require manual intervention.
- Real-world data further strengthens the case for robotic PCI
Users of the CorPath System presented compelling real-world data on system usage. One physician presented his experience of completing first eighty CorPath cases. 87% of those cases were type B/C lesions. After the first 20 robotic cases, the physician expertise and effectiveness in complex cases was further increased. In a study published in JACC earlier this year Dr. Campbell shared real-world data of sixty consecutive patients who underwent coronary stent placement utilizing the CorPath System. The treating physician assessed orthogonal images and provided visual estimates of lesion length and Stent Length Selection (SLS). They concluded that manual assessment of lesion length and SLS is highly variable with 65% of the cases being inaccurately measured when compared to objective measures obtained from the robotic system. In 32% of the cases lesions were visually estimated to be shorter representing cases that often require the use of extra stents after the full lesion is not covered by 1 stent [Longitudinal Geographic Miss (LGM)]. Further, these data showed that the use of the robotic system prevented the use of extra stents in 8.3% of the cases1.
CorPath user meetings enable robotics thought leaders to interact and share best practices that may someday become standard of care. Existing CorPath physician users are invited to join us at Society for Cardiac Angiography and Interventions (SCAI) conference on Friday, May 8th in San Diego, CA for the next users meeting. As early adopters of this revolutionizing technology your inputs are immensely valuable. We urge you to come, and to share your insights and experiences!
- Paul T. Campbell, Kevin R. Kruse, et al. The Impact of Precise Robotic Lesion Length Measurement on Stent Length Selection: Ramifications For Stent Savings.JACC Cardiovasc Interv. 2015;8(2_S):S26-S26